39,508 Shares in Teladoc Health, Inc. (NYSE:TDOC) Purchased by Scientech Research LLC

Scientech Research LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 39,508 shares of the health services provider’s stock, valued at approximately $386,000.

Several other hedge funds have also recently bought and sold shares of TDOC. Parallel Advisors LLC grew its position in shares of Teladoc Health by 14.6% in the fourth quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock valued at $87,000 after purchasing an additional 515 shares during the last quarter. Ignite Planners LLC increased its position in Teladoc Health by 6.9% during the 1st quarter. Ignite Planners LLC now owns 13,307 shares of the health services provider’s stock worth $198,000 after buying an additional 857 shares during the period. ICA Group Wealth Management LLC acquired a new stake in shares of Teladoc Health during the fourth quarter worth $28,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Teladoc Health by 2.1% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,588 shares of the health services provider’s stock valued at $641,000 after acquiring an additional 1,352 shares during the period. Finally, Covestor Ltd grew its stake in shares of Teladoc Health by 58.1% in the first quarter. Covestor Ltd now owns 3,817 shares of the health services provider’s stock valued at $57,000 after acquiring an additional 1,403 shares in the last quarter. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Price Performance

Shares of NYSE:TDOC opened at $8.46 on Monday. Teladoc Health, Inc. has a one year low of $6.76 and a one year high of $22.54. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. The company has a market cap of $1.43 billion, a price-to-earnings ratio of -6.00 and a beta of 0.90. The firm has a 50 day simple moving average of $7.93 and a 200 day simple moving average of $10.62.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings results on Wednesday, July 31st. The health services provider reported ($0.28) EPS for the quarter, beating analysts’ consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative return on equity of 10.25% and a negative net margin of 38.54%. The company had revenue of $642.44 million during the quarter, compared to analysts’ expectations of $649.34 million. Research analysts predict that Teladoc Health, Inc. will post -1.18 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on the stock. Piper Sandler cut their price objective on shares of Teladoc Health from $25.00 to $10.00 and set an “overweight” rating for the company in a report on Tuesday, August 6th. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Thursday, August 1st. Truist Financial dropped their price objective on Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a report on Friday, August 2nd. Deutsche Bank Aktiengesellschaft reduced their target price on Teladoc Health from $15.00 to $10.00 and set a “hold” rating on the stock in a report on Friday, August 2nd. Finally, Oppenheimer dropped their price target on Teladoc Health from $21.00 to $17.00 and set an “outperform” rating for the company in a research note on Thursday, August 1st. Fifteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $12.31.

Insider Buying and Selling at Teladoc Health

In other news, insider Vidya Raman-Tangella sold 3,857 shares of the business’s stock in a transaction dated Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $31,395.98. Following the sale, the insider now directly owns 33,667 shares in the company, valued at $274,049.38. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $8.14, for a total transaction of $31,395.98. Following the transaction, the insider now owns 33,667 shares in the company, valued at $274,049.38. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CFO Mala Murthy sold 8,750 shares of the stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $7.16, for a total value of $62,650.00. Following the completion of the sale, the chief financial officer now owns 85,767 shares of the company’s stock, valued at $614,091.72. The disclosure for this sale can be found here. Over the last three months, insiders sold 57,819 shares of company stock worth $442,204. 0.95% of the stock is currently owned by insiders.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.